EKSO Ekso Bionics® Unveils the Next Generation Exoskeleton

GlobeNewswire•August 15, 2019

RICHMOND, Calif., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO), a leading developer of exoskeletons for medical and industrial use, today unveiled EksoNR, the next generation EksoGT— the most clinically used robotic exoskeleton. Developed for neurorehabilitation, EksoNR is an intuitive exoskeleton device that empowers patients recovering from stroke or other conditions to learn to walk again with a more natural gait. The device now includes new features and software enhancements to help physical therapists and patients get even more out of each rehabilitation session.

EksoNR is equipped with EksoView, a new touchscreen controller that allows therapists to intuitively adapt assistance to challenge patients using real-time feedback and perform outcome measures during use. Held in the palm of a therapists’ hand, EksoView provides visualization of various exercises beyond gait training, such as balancing, squatting from sit-to-stand positioning, lifting one leg, or standing in place, to actively engage patients and enhance the use of these beneficial features.

The optimized SmartAssist software enables EksoNR to have a smoother and more natural gait path when transitioning between steps. SmartAssist also gives gait symmetry and posture feedback and allows therapists to track patient progress with the upgraded EksoPulse, a cloud-based analytics solution. EksoPulse now uses rehabilitation data to generate insightful metrics and graphs for therapists and administrators to monitor patient progress and outcomes.

“Ekso Bionics is committed to developing the latest exoskeleton advances for rehabilitation. We continue to innovate to ensure physical therapists have access to the latest tools to deliver better patient outcomes and superior care in neurorehabilitation,” said Jack Peurach, Chief Executive Officer and President of Ekso Bionics. “EksoNR is a full neurorehabilitation tool that is effective, intuitive, and differentiating. There is an increasing demand for adoption, as our technology sets rehabilitation centers apart.”

EksoNR is cleared by the U.S. Federal Drug Administration for stroke and spinal cord injury rehabilitation. The device is also CE-marked and available in Europe.

Ekso Bionics will begin taking orders for EksoNR immediately. Existing customers will have the option to upgrade.

About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com.